Revelation Biosciences raises $9.6M via immediate exercise of existing warrants

REVELATION BIOSCIENCES, INC.

$9.6M gross proceeds from exercise of 13,065,000 existing warrants at $2.20/share.
Issued 13,065,000 new Class I warrants at same $2.20 price, exercisable after stockholder approval for 5 years.
Existing warrants covered 4,355,000 shares; new warrants cover 13,065,000 shares (higher dilution).
Proceeds to fund clinical development and working capital.
Roth Capital Partners acted as financial advisor for 8% cash fee on gross proceeds.

item 1.01item 3.02item 3.03item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.